In the oxazolone and SADBE (squaric acid dibutyl ester) models of allergic contract dermatitis (ACD), the KO of TRPA1 reduced skin inflammation, skin edema, keratinocyte hyperplasia, and scratching behaviors [44,45]. Here, TRPA1 is linked to dermatitis.